Embecta (EMBC) Cash & Current Investments (2022 - 2026)
Embecta (EMBC) posted Cash & Current Investments of $193.4 million for Q1 2026, down 5.38% sequentially from $204.4 million in Q4 2025, and down 8.9% YoY from $212.3 million in Q1 2025.
Embecta (EMBC) Cash & Current Investments (2022 - 2026) Analysis & Trends
Embecta has reported Cash & Current Investments for 5 years, with the latest figure at $193.4 million in Q1 2026.
- Quarterly Cash & Current Investments fell 8.9% year-over-year to $193.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $193.4 million (down 8.9% YoY) and the FY2025 annual result came in at $228.6 million, down 16.63% from the prior year.
- Cash & Current Investments fell to $193.4 million in Q1 2026 per EMBC's latest filing, from $204.4 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $385.2 million in Q4 2022 and troughed at $193.4 million in Q1 2026.
- A 5-year average of $277.2 million and a median of $281.8 million in 2024 frame the typical range for Cash & Current Investments.
- The sharpest annual moves came in 2023 and 2025: Cash & Current Investments jumped 31.06% in 2023, then tumbled 30.73% in 2025.
- Over 5 years, Cash & Current Investments stood at $385.2 million in 2022, then declined by 22.46% to $298.7 million in 2023, then slipped by 27.45% to $216.7 million in 2024, then decreased by 5.68% to $204.4 million in 2025, then fell by 5.38% to $193.4 million in 2026.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $193.4 million, $204.4 million, and $228.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 5.22 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 863.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 1.36 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 1.47 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 2.68 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 435.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 403.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 138.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 2.15 Bn |
| 10 | Embecta | 305.26 Mn | 87.06 Mn | 153.30 Mn | 218.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 218.20 Mn |
| Mar 31, 2026 | 193.40 Mn |
| Dec 31, 2025 | 204.40 Mn |
| Sep 30, 2025 | 228.60 Mn |
| Jun 30, 2025 | 233.60 Mn |
| Mar 31, 2025 | 212.30 Mn |
| Dec 31, 2024 | 216.70 Mn |
| Sep 30, 2024 | 274.20 Mn |
| Jun 30, 2024 | 281.80 Mn |
| Mar 31, 2024 | 306.50 Mn |
| Dec 31, 2023 | 298.70 Mn |
| Sep 30, 2023 | 326.50 Mn |
| Jun 30, 2023 | 317.40 Mn |
| Mar 31, 2023 | 346.40 Mn |
| Dec 31, 2022 | 385.20 Mn |
| Sep 30, 2022 | 330.90 Mn |
| Jun 30, 2022 | 292.30 Mn |
| Mar 31, 2022 | 264.30 Mn |